Jane Street’s Kindred Biosciences, Inc. KIN Stock Holding History

Jane Street’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-43,400	Closed	-$398K	–	11223
2021 Q2	$398K	Buy	+43,400	New	+$252K	﹤0.01%	7675

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Jane Street's KIN Position: Q3 2021 in Review

Jane Street sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 162,930 shares — an estimated $1.49M sold.

Jane Street first reported a position in KIN in Q2 2014 and held it in 2 quarters. The position peaked at $1.49M in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Jane Street reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Jane Street sold 162,930 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $1.49M.
Jane Street first reported a position in Kindred Biosciences, Inc. in Q2 2014 and held it in 2 quarters.
Jane Street's Kindred Biosciences, Inc. position peaked at $1.49M in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.